Golimumab Subcutaneous and Revonto
Determining the interaction of Golimumab Subcutaneous and Revonto and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: golimumab
Brand name: Simponi, Simponi SmartJect, Simponi Aria
Synonyms: Golimumab
Generic Name: dantrolene
Brand name: Dantrium, Revonto, Dantrium Intravenous, Ryanodex
Synonyms: Revonto Injection
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Golimumab Subcutaneous-Revonto Injection
- Golimumab Subcutaneous-Rexaphenac
- Golimumab Subcutaneous-Rexulti
- Golimumab Subcutaneous-Reyataz
- Golimumab Subcutaneous-Reyataz (Atazanavir Capsules)
- Golimumab Subcutaneous-Reyataz (Atazanavir Powder for Oral Suspension)
- Revonto-GoLYTELY
- Revonto-Gonadorelin
- Revonto-Gonadorelin Intravenous, Injection
- Revonto-Gonadotropin, Chorionic
- Revonto-Gonal-F
- Revonto-Gonal-f RFF